Digraph

2020-02 CRISPR-engineered T cells in patients with refractory cancer

Parent topics

Crispr-Cas9

This topic

Recent activity

You must be signed in to add and move topics and links.

CRISPR-Edited Immune Cells Can Survive and Thrive After Infusion into Cancer Patients – PR News
https://www.pennmedicine.org/news/news-releases/2020/february/crispr-edited-immune-cells-can-survive-and-thrive-after-infusion-into-cancer-patients
2020-02 CRISPR-engineered T cells in patients with refractory cancer
CRISPR-engineered T cells in patients with refractory cancer
https://science.sciencemag.org/content/early/2020/02/05/science.aba7365
2020-02 CRISPR-engineered T cells in patients with refractory cancer
Science Papers Describe CRISPR Alteration of T Cells for Cancer Patients, Sewage-Based Antimicrobial Resistance Surveillance, More | GenomeWeb
https://www.genomeweb.com/scan/science-papers-describe-crispr-alteration-t-cells-cancer-patients-sewage-based-antimicrobial
2020-02 CRISPR-engineered T cells in patients with refractory cancer 2020-02 Using sewage for surveillance of antimicrobial resistance